Sign In
Buy ZBH
$93.93
-1.03 (-1.08%)
At Close: Jul 31, 2026
Zimmer Biomet Announces Second Quarter 2025 Financial Results
06:30am, Thursday, 07'th Aug 2025
Second quarter net sales of $2.077 billion increased 7.0% on a reported basis, 5.4% on a constant currency1 basis and 2.8% on an organic constant currency1 basis Second quarter diluted earnings per sh
Exploring Analyst Estimates for Zimmer (ZBH) Q2 Earnings, Beyond Revenue and EPS
10:15am, Tuesday, 05'th Aug 2025
Get a deeper insight into the potential performance of Zimmer (ZBH) for the quarter ended June 2025 by going beyond Wall Street's top-and-bottom-line estimates and examining the estimates for some of
Zimmer Biomet to Report Q2 Earnings: Here's What to Expect
09:31am, Monday, 04'th Aug 2025
ZBH's Q2 results may show strength in Hips, Knees, and S.E.T. despite a projected year-over-year earnings dip.
Analysts Estimate Zimmer Biomet (ZBH) to Report a Decline in Earnings: What to Look Out for
11:06am, Thursday, 31'st Jul 2025
Zimmer (ZBH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zimmer Biomet Q2 Preview: Combining Monogram Autonomous Robotics With ROSA
12:50pm, Monday, 21'st Jul 2025
I reiterate my Buy rating on Zimmer Biomet Holdings, Inc., setting a fair value of $133 per ZBH share due to strong business acceleration opportunities. The Monogram Technologies acquisition could sig
ZBH Stock Set to Benefit From New Monogram Technologies Buyout Deal
10:51am, Thursday, 17'th Jul 2025
Zimmer Biomet eyes long-term gains with the $177M Monogram buyout, aiming to expand its robotic knee surgery offerings by 2027.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earnings pe
Proposed transaction creates the broadest, most flexible portfolio of orthopedic robotics and navigation technologies to meet surgeons' needs Acquisition expected to be neutral to adjusted earning
Final Trades: Uber, Delta, Zimmer Holdings and Boeing
02:21pm, Friday, 11'th Jul 2025
The Investment Committee give you their top stocks to watch for the second half.
Zimmer Biomet Announces Webcast and Conference Call of Second Quarter 2025 Financial Results
07:30am, Wednesday, 09'th Jul 2025
WARSAW, Ind. , July 9, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced its second quarter earnings conference call will be webcast on Thursday, August 7, 2025 at
Why Is Zimmer (ZBH) Down 0.5% Since Last Earnings Report?
12:36pm, Wednesday, 04'th Jun 2025
Zimmer (ZBH) reported earnings 30 days ago. What's next for the stock?
Zimmer Biomet Appoints Kevin Thornal as Group President, Global Businesses and the Americas
07:30am, Tuesday, 27'th May 2025
WARSAW, Ind. , May 27, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced the appointment of Kevin Thornal as Group President, G
Zimmer Biomet to Present at the Goldman Sachs 46th Annual Global Healthcare Conference
07:30am, Thursday, 22'nd May 2025
WARSAW, Ind., May 22, 2025 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today announced that members of the Zimmer Biomet management team will be presenting at the Goldman Sachs 4
We pay attention to policy and patients, says Zimmer Biomet CEO Ivan Tornos
06:04pm, Tuesday, 20'th May 2025
Ivan Tornos, Zimmer Biomet CEO, joins 'Closing Bell Overtime' from the CNBC CEO Council Summit to talk navigating a changing political landscape, partnering with Arnold Schwarzenegger and more.
